Suppr超能文献

发现一种具有促神经发生和神经保护作用的化学物质。

Discovery of a proneurogenic, neuroprotective chemical.

机构信息

Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9152, USA.

出版信息

Cell. 2010 Jul 9;142(1):39-51. doi: 10.1016/j.cell.2010.06.018.

Abstract

An in vivo screen was performed in search of chemicals capable of enhancing neuron formation in the hippocampus of adult mice. Eight of 1000 small molecules tested enhanced neuron formation in the subgranular zone of the dentate gyrus. Among these was an aminopropyl carbazole, designated P7C3, endowed with favorable pharmacological properties. In vivo studies gave evidence that P7C3 exerts its proneurogenic activity by protecting newborn neurons from apoptosis. Mice missing the gene encoding neuronal PAS domain protein 3 (NPAS3) are devoid of hippocampal neurogenesis and display malformation and electrophysiological dysfunction of the dentate gyrus. Prolonged administration of P7C3 to npas3(-/-) mice corrected these deficits by normalizing levels of apoptosis of newborn hippocampal neurons. Prolonged administration of P7C3 to aged rats also enhanced neurogenesis in the dentate gyrus, impeded neuron death, and preserved cognitive capacity as a function of terminal aging. PAPERCLIP:

摘要

进行了一项体内筛选实验,旨在寻找能够增强成年小鼠海马体神经元形成的化学物质。在测试的 1000 种小分子中,有 8 种能够增强齿状回颗粒下区的神经元形成。其中一种被称为 P7C3 的氨基丙基咔唑具有良好的药理学特性。体内研究表明,P7C3 通过保护新生神经元免于凋亡来发挥其促神经发生活性。缺失编码神经元 PAS 结构域蛋白 3(NPAS3)的基因的小鼠缺乏海马神经发生,并表现出齿状回的畸形和电生理功能障碍。将 P7C3 长期给予 npas3(-/-) 小鼠,可通过使新生海马神经元凋亡水平正常化来纠正这些缺陷。将 P7C3 长期给予老年大鼠也增强了齿状回的神经发生,阻止了神经元死亡,并保持了与终末衰老相关的认知能力。

相似文献

1
Discovery of a proneurogenic, neuroprotective chemical.
Cell. 2010 Jul 9;142(1):39-51. doi: 10.1016/j.cell.2010.06.018.
2
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease.
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17010-5. doi: 10.1073/pnas.1213956109. Epub 2012 Oct 1.
3
Neuroprotective efficacy of P7C3 compounds in primate hippocampus.
Transl Psychiatry. 2018 Sep 26;8(1):202. doi: 10.1038/s41398-018-0244-1.
4
Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury.
J Neurotrauma. 2014 Mar 1;31(5):476-86. doi: 10.1089/neu.2013.3135. Epub 2013 Dec 19.
5
The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic stroke.
Exp Neurol. 2017 Apr;290:63-73. doi: 10.1016/j.expneurol.2017.01.006. Epub 2017 Jan 8.
6
Development of proneurogenic, neuroprotective small molecules.
J Am Chem Soc. 2011 Feb 9;133(5):1428-37. doi: 10.1021/ja108211m. Epub 2011 Jan 6.
8
Chronic P7C3 treatment restores hippocampal neurogenesis in the Ts65Dn mouse model of Down Syndrome [Corrected].
Neurosci Lett. 2015 Mar 30;591:86-92. doi: 10.1016/j.neulet.2015.02.008. Epub 2015 Feb 7.
9
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis.
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17016-21. doi: 10.1073/pnas.1213960109. Epub 2012 Oct 1.
10
The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice.
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14052-7. doi: 10.1073/pnas.0506713102. Epub 2005 Sep 19.

引用本文的文献

1
Inhibiting 15-PGDH blocks blood-brain barrier deterioration and protects mice from Alzheimer's disease and traumatic brain injury.
Proc Natl Acad Sci U S A. 2025 May 27;122(21):e2417224122. doi: 10.1073/pnas.2417224122. Epub 2025 May 21.
2
Regulation of Stem Cell Function by NAD.
Physiology (Bethesda). 2025 Jul 1;40(4):0. doi: 10.1152/physiol.00052.2024. Epub 2025 Feb 5.
3
4
5
Acutely blocking excessive mitochondrial fission prevents chronic neurodegeneration after traumatic brain injury.
Cell Rep Med. 2024 Sep 17;5(9):101715. doi: 10.1016/j.xcrm.2024.101715. Epub 2024 Sep 5.
7
Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features.
Curr Alzheimer Res. 2024 Jul 29. doi: 10.2174/0115672050319219240711103459.
10
Higher concentration of P7C3 than required for neuroprotection suppresses renal cell carcinoma growth and metastasis.
J Cancer. 2024 Jan 1;15(5):1191-1202. doi: 10.7150/jca.90439. eCollection 2024.

本文引用的文献

1
Association of NPAS3 exonic variation with schizophrenia.
Schizophr Res. 2010 Jul;120(1-3):143-9. doi: 10.1016/j.schres.2010.04.002. Epub 2010 May 14.
2
Pharmacology. The puzzling rise and fall of a dark-horse Alzheimer's drug.
Science. 2010 Mar 12;327(5971):1309. doi: 10.1126/science.327.5971.1309.
4
Antidepressants increase neural progenitor cells in the human hippocampus.
Neuropsychopharmacology. 2009 Oct;34(11):2376-89. doi: 10.1038/npp.2009.75. Epub 2009 Jul 15.
6
A promising new treatment for Alzheimer's disease?
Lancet Neurol. 2008 Sep;7(9):768-9. doi: 10.1016/S1474-4422(08)70177-7.
8
Dimebon in Alzheimer's disease: old drug for new indication.
Lancet. 2008 Jul 19;372(9634):179-80. doi: 10.1016/S0140-6736(08)61046-6.
9
Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder.
Mol Psychiatry. 2009 Sep;14(9):874-84. doi: 10.1038/mp.2008.24. Epub 2008 Mar 4.
10
Life cell quantification of mitochondrial membrane potential at the single organelle level.
Cytometry A. 2008 Feb;73(2):129-38. doi: 10.1002/cyto.a.20503.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验